| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $63.6M | +107.8% |
| SG&A Expense | $18.8M | +102.4% |
| Operating Income | -$82.4M | -106.5% |
| Pre-tax Income | -$67.8M | -30.5% |
| Income Tax | $180K | +3500.0% |
| Net Income | -$68.0M | -30.8% |
| EPS (Basic) | -$4.05 | +95.5% |
| EPS (Diluted) | -$4.05 | +95.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $489.7M | +112.5% |
| Current Assets | $502.5M | +117.5% |
| Total Assets | $510.0M | +118.0% |
| Current Liabilities | $18.0M | +19.3% |
| Total Liabilities | $18.1M | +17.1% |
| Stockholders' Equity | $491.9M | +430.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$74.8M | -63.8% |
| Capital Expenditures | $71K | -87.9% |
| Investing Cash Flow | -$9K | +98.5% |
| Financing Cash Flow | $334.0M | +22.6% |
| Free Cash Flow | -$74.8M | -61.9% |